Conmed
A global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services.
Launch date
Employees
Market cap
€2.2b
Enterprise valuation
€3.0b (Public information from Sep 2024)
Share price
$75.35 CNMD
Largo Florida (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 862m | 1.0b | 1.0b | 1.2b | 1.3b | 1.4b | 1.5b |
% growth | (10 %) | 17 % | 3 % | 19 % | 5 % | 8 % | 7 % |
EBITDA | 45.7m | 109m | (42.0m) | 192m | 260m | 290m | 321m |
% EBITDA margin | 5 % | 11 % | (4 %) | 15 % | 20 % | 21 % | 21 % |
Profit | 9.5m | 62.5m | (80.6m) | 64.5m | 108m | 141m | 175m |
% profit margin | 1 % | 6 % | (8 %) | 5 % | 8 % | 10 % | 12 % |
EV / revenue | 4.6x | 4.8x | 3.6x | 3.5x | 2.4x | 2.2x | 2.0x |
EV / EBITDA | 86.1x | 44.3x | -88.8x | 22.4x | 12.0x | 10.6x | 9.3x |
R&D budget | 40.5m | 43.6m | 47.2m | 52.6m | - | - | - |
R&D % of revenue | 5 % | 4 % | 5 % | 4 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
* | N/A | $700m | Post IPO Debt |
Total Funding | - |
Related Content
Recent News about Conmed
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Conmed
EditACQUISITION by Conmed Nov 2015
ACQUISITION by Conmed Aug 2022
ACQUISITION by Conmed May 2022